M. Hockel, PERSPECTIVES FOR SURGICAL GYNECOLOGY IN T HE TREATMENT OF CERVICAL-CANCER, Gynakologisch-geburtshilfliche Rundschau, 35(3), 1995, pp. 133-138
Both the gain of new tumor biological insights, particularly the relev
ance of tumor oxygenation and vascularity in addition to tumor volume
for disease progression and resistance towards therapy, and the develo
pment of novel ablative and reconstructive pelvic surgical techniques
may lead to a paradigm shift in the treatment of cancer of the uterine
cervix. With respect to stage, size, and predicted tumor biological f
eatures, either less radical or extended radical surgical treatment sh
ould be investigated in clinical trials with standard therapy (abdomin
al radical hysterectomy and pelvic/periaortic lymph node dissection fo
r early-stage disease and percutaneous/intracavitary radiation for loc
ally advanced disease) as control. Improving the therapeutic index and
increasing the therapeutic window in cervical cancer appear to be an
exciting challenge for surgical gynecology in the future.